Advertisement
News
Subscribe to MDT Magazine News

Energy commission approves first clean energy business loan

August 30, 2010 10:38 am | by I-Micronews | Comments

Solar cell manufacturer receives financial boost

ISET demonstrates low-cost printed CIGS module

August 30, 2010 10:38 am | by I-Micronews | Comments

Manufacturing on pilot production line

MIT scientists discover way to make sponges' cancer-fighting chemicals

August 30, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

MIT researchers have figured out a way to synthesize six chemicals emitted by ocean sponges that play a role in interfering with cancer growth, as well as repressing a target enzyme linked to Alzheimer's disease.

Advertisement

Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study

August 30, 2010 10:33 am | by Bio-Medicine.Org | Comments

NASHVILLE, Tenn., Aug. 30 /- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of new data supporting the safety and efficacy of Caldolor® ( ibuprofen ) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the...

TOPICS:

Covidien wraps up sale of sleep products unit

August 30, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Covidien plc today said that it has completed the sale of its sleep therapy product line, a deal that the company announced in June as part of a series of divestment and acquisition moves.

Kopp Drug Selects Activant Eagle Solution

August 30, 2010 7:33 am | by Bio-Medicine.Org | Comments

LIVERMORE, Calif., Aug. 30 /- Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale (POS) solution....

TOPICS:

BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease

August 30, 2010 7:33 am | by Bio-Medicine.Org | Comments

NOVATO, Calif., Aug. 30 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development...

TOPICS:

Inc. Magazine Unveils 29th Annual List of America's Fastest-Growing Private Companiesâ??the Inc. 500

August 30, 2010 7:33 am | by Bio-Medicine.Org | Comments

HOUSTON, Aug. 30 /- eCardio announced today their inclusion on the Inc. magazine's annual list of America's fastest-growing private companies-the Inc. 500. Inc. magazine released the list on August 24, and eCardio was included at #435 with a three-year sales growth of 642%. (Logo:...

TOPICS:
Advertisement

Bioheart's MyoCell Recognized as one of the Breakthrough Developments of 2010

August 30, 2010 7:32 am | by Bio-Medicine.Org | Comments

SUNRISE, Fla., Aug. 30 /- Bioheart, Inc. - (OTC Bulletin Board: BHRT ) The mission of the Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education. The Foundation aims to promote basic and applied knowledge, processes and...

TOPICS:

West Physics Consulting Lands on the 2010 Inc. 5000 List

August 30, 2010 7:31 am | by Bio-Medicine.Org | Comments

ATLANTA and NEW YORK, Aug. 30 /- Inc. magazine has ranked West Physics Consulting, LLC No. 2230 on its fourth annual Inc. 5000 list, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the...

TOPICS:

3M to acquire Cogent for about $943 million

August 30, 2010 6:45 am | by The Associated Press | Comments

3M Co., which makes products ranging from Post-Its to respirators, computer arms, and films for LCD TV screens, said Monday it has agreed to acquire Cogent Inc. in a deal worth about $943 million.Cogent, based in Pasadena, Calif., develops automated systems that read finger and palm prints. The...

Genzyme rejects Sanofi bid

August 30, 2010 6:31 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. has said the company is not for sale to French drug maker Sanofi-Aventis for the price of $69 a share, confirming weeks of rumors that the two companies were in tense negotiations over a possible acquisition.

Study identifies risk factors for cardiovascular events in patients with atherothrombosis

August 30, 2010 5:36 am | by EurekAlert | Comments

(JAMA and Archives Journals) Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the Sept. 22...

TOPICS:

Omnivision first company to implement BSI technology on VGA CMOS image sensors

August 30, 2010 5:36 am | by I-Micronews | Comments

OmniVision Technologies recently introduced the OV7727, a top-of-the-line VGA sensor for the high-end ultra-thin notebook market. It is the first VGA sensor built with OmniBSI? backside illumination technology. It combines extremely strong performance and sensitivity with an ultra-compact...

Intel on beyond 32nm CMOS and 3D TSV plans

August 30, 2010 5:35 am | by I-Micronews | Comments

The limit of scaling down CMOS transistors, which are elementary elements of chips, has long been pointed out. But it seems that the limit still cannot be seen according to a recent interview of Nikkei Microdevices with Kelin J Kuhn, Inte's Director of Advanced Device Technology.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading